The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms

By sjmartinez • March 25, 2025

Solomon DH, Paudel M, Chitineni S, Fernandes A, Pham T, Billa S, Yokose C, Tan K, Dedier JJ, Dubreuil MD, Fitzgerald JD, Hodder SL, Neogi T, Pillinger MH, Riggs KR, Saag KG, Shekelle PG, Tseng Z, Toprover M, Wei DS, Barry MJ, Choi HK. The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms. ACR Open Rheumatol. 2025 Mar;7(3):e70012. doi: 10.1002/acr2.70012. PMID: 40126890.

Tags: General Internal Medicine, Publications, Rheumatology, Veterans Administration

Racial and Ethnic Disparities in Diabetes Prevention Outcomes: Insights from the Prediabetes Informed Decisions and Education Study

Castellon-Lopez Y, Duru OK, Turk N, Moreno G, Norris KC, Vu A, Saju RP, Tseng CH, Skrine-Jeffers K, Mangione CM, Frosch D, Moin T. Racial[...]

Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD

Truong E, Alnimer L, Gornbein JA, Yang JD, Alkhouri N, Harrison SA, Noureddin M. Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes,[...]

Practical Steps to Advance Health Equity in Research from the UCLA COVID-19 Health Equity Research and Advisory Committee

Castillo EG, Guerrero AD, Bath EPJ, Dicker RA, Esrailian E, Hansen H, Harawa NT, Taira BR, Harris C. Practical Steps to Advance Health Equity in[...]